BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 23392401)

  • 1. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
    Pista A; de Oliveira CF; Lopes C; Cunha MJ;
    Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.
    Berois N; De Cremoux P; Mazal D; Sica A; Cedeira M; Caserta B; Barrios E; Osinaga E; Sastre-Garau X
    Int J Gynecol Cancer; 2013 Mar; 23(3):527-32. PubMed ID: 23392403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
    Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
    Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
    Hooi DJ; Lissenberg-Witte BI; de Koning MNC; Pinedo HM; Kenter GG; Meijer CJ; Quint WG
    Sex Transm Infect; 2018 Jun; 94(4):263-267. PubMed ID: 29021405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.
    Pérez-Castro S; Lorenzo-Mahía Y; Iñarrea Fernández A; Lamas-González MJ; Sarán-Díez MT; Rubio-Alarcón J; Reboredo-Reboredo MC; Mosteiro-Lobato S; López-Miragaya I; Torres-Piñón J; Melón-García S
    Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):479-85. PubMed ID: 24274937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-type distribution and reproducibility of histological diagnosis in cervical neoplasia in Poland.
    Nowakowski A; de Souza SC; Jach R; Rosillon D; Książek A; Holl K
    Pathol Oncol Res; 2015 Jul; 21(3):703-11. PubMed ID: 25547828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.
    Pista A; de Oliveira CF; Lopes C; Cunha MJ;
    Int J Gynaecol Obstet; 2017 Oct; 139(1):90-94. PubMed ID: 28632949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
    Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
    Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.
    Futai M; Watanabe J; Jobo T; Tsunoda S; Nishimura Y; Watanabe K; Okayasu I; Unno N
    Int J Gynecol Cancer; 2009 Nov; 19(8):1396-401. PubMed ID: 20009896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
    Castle PE; Shaber R; LaMere BJ; Kinney W; Fetterma B; Poitras N; Lorey T; Schiffman M; Dunne A; Ostolaza JM; McKinney S; Burk RD
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):946-53. PubMed ID: 21415357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
    Guan P; Howell-Jones R; Li N; Bruni L; de Sanjosé S; Franceschi S; Clifford GM
    Int J Cancer; 2012 Nov; 131(10):2349-59. PubMed ID: 22323075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
    Quek SC; Lim BK; Domingo E; Soon R; Park JS; Vu TN; Tay EH; Le QT; Kim YT; Vu BQ; Cao NT; Limson G; Pham VT; Molijn A; Ramakrishnan G; Chen J
    Int J Gynecol Cancer; 2013 Jan; 23(1):148-56. PubMed ID: 23221730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study.
    Wu EQ; Liu B; Cui JF; Chen W; Wang JB; Lu L; Niyazi M; Zhao C; Ren SD; Li CQ; Gong XZ; Smith JS; Belinson JL; Liaw KL; Velicer C; Qiao YL
    Cancer Causes Control; 2013 Apr; 24(4):795-803. PubMed ID: 23397310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women.
    Suthipintawong C; Siriaunkgul S; Tungsinmunkong K; Pientong C; Ekalaksananan T; Karalak A; Kleebkaow P; Vinyuvat S; Triratanachat S; Khunamornpong S; Chongsuwanich T
    Asian Pac J Cancer Prev; 2011; 12(4):853-6. PubMed ID: 21790214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
    Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
    BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cancer patients: Sharkia Governorate, Egypt.
    Abd El-Azim S; Lotfy M; Omr A
    Clin Lab; 2011; 57(5-6):363-71. PubMed ID: 21755827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papilloma Virus Genotype Distribution in Cervical lesions in Zanjan, Iran.
    Ahmadi S; Goudarzi H; Jalilvand A; Esmaeilzadeh A
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3373-3377. PubMed ID: 29286606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
    Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
    Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.